250 related articles for article (PubMed ID: 31149044)
1. Inhibition of protein disulfide isomerase in glioblastoma causes marked downregulation of DNA repair and DNA damage response genes.
Xu S; Liu Y; Yang K; Wang H; Shergalis A; Kyani A; Bankhead A; Tamura S; Yang S; Wang X; Wang CC; Rehemtulla A; Ljungman M; Neamati N
Theranostics; 2019; 9(8):2282-2298. PubMed ID: 31149044
[TBL] [Abstract][Full Text] [Related]
2. Activation of the Unfolded Protein Response via Inhibition of Protein Disulfide Isomerase Decreases the Capacity for DNA Repair to Sensitize Glioblastoma to Radiotherapy.
Liu Y; Ji W; Shergalis A; Xu J; Delaney AM; Calcaterra A; Pal A; Ljungman M; Neamati N; Rehemtulla A
Cancer Res; 2019 Jun; 79(11):2923-2932. PubMed ID: 30996048
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Biological Evaluation of Novel Allosteric Protein Disulfide Isomerase Inhibitors.
Yang S; Shergalis A; Lu D; Kyani A; Liu Z; Ljungman M; Neamati N
J Med Chem; 2019 Apr; 62(7):3447-3474. PubMed ID: 30759340
[TBL] [Abstract][Full Text] [Related]
4. Discovery and Mechanistic Elucidation of a Class of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma.
Kyani A; Tamura S; Yang S; Shergalis A; Samanta S; Kuang Y; Ljungman M; Neamati N
ChemMedChem; 2018 Jan; 13(2):164-177. PubMed ID: 29235250
[TBL] [Abstract][Full Text] [Related]
5. Novel Protein Disulfide Isomerase Inhibitor with Anticancer Activity in Multiple Myeloma.
Vatolin S; Phillips JG; Jha BK; Govindgari S; Hu J; Grabowski D; Parker Y; Lindner DJ; Zhong F; Distelhorst CW; Smith MR; Cotta C; Xu Y; Chilakala S; Kuang RR; Tall S; Reu FJ
Cancer Res; 2016 Jun; 76(11):3340-50. PubMed ID: 27197150
[TBL] [Abstract][Full Text] [Related]
6. Role of the ERO1-PDI interaction in oxidative protein folding and disease.
Shergalis AG; Hu S; Bankhead A; Neamati N
Pharmacol Ther; 2020 Jun; 210():107525. PubMed ID: 32201313
[TBL] [Abstract][Full Text] [Related]
7. A substrate-driven allosteric switch that enhances PDI catalytic activity.
Bekendam RH; Bendapudi PK; Lin L; Nag PP; Pu J; Kennedy DR; Feldenzer A; Chiu J; Cook KM; Furie B; Huang M; Hogg PJ; Flaumenhaft R
Nat Commun; 2016 Aug; 7():12579. PubMed ID: 27573496
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an A-Site Selective Protein Disulfide Isomerase A1 Inhibitor.
Cole KS; Grandjean JMD; Chen K; Witt CH; O'Day J; Shoulders MD; Wiseman RL; Weerapana E
Biochemistry; 2018 Apr; 57(13):2035-2043. PubMed ID: 29521097
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Aminobenzylphenols as Protein Disulfide Isomerase Inhibitors in Glioblastoma Cell Lines.
Shergalis A; Xue D; Gharbia FZ; Driks H; Shrestha B; Tanweer A; Cromer K; Ljungman M; Neamati N
J Med Chem; 2020 Sep; 63(18):10263-10286. PubMed ID: 32830969
[TBL] [Abstract][Full Text] [Related]
10. Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress.
Lovat PE; Corazzari M; Armstrong JL; Martin S; Pagliarini V; Hill D; Brown AM; Piacentini M; Birch-Machin MA; Redfern CP
Cancer Res; 2008 Jul; 68(13):5363-9. PubMed ID: 18593938
[TBL] [Abstract][Full Text] [Related]
11. Protein disulfide isomerase: a promising target for cancer therapy.
Xu S; Sankar S; Neamati N
Drug Discov Today; 2014 Mar; 19(3):222-40. PubMed ID: 24184531
[TBL] [Abstract][Full Text] [Related]
12. Challenges in the evaluation of thiol-reactive inhibitors of human protein disulfide Isomerase.
Foster CK; Thorpe C
Free Radic Biol Med; 2017 Jul; 108():741-749. PubMed ID: 28465261
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Neuroblastoma Cells with Inhibitors of Protein Disulfide Isomerase Upregulates NQO1 Activity.
Özcelik D
Chem Res Toxicol; 2020 Aug; 33(8):2099-2107. PubMed ID: 32662633
[TBL] [Abstract][Full Text] [Related]
14. Chemical stress on protein disulfide isomerases and inhibition of their functions.
Imaoka S
Int Rev Cell Mol Biol; 2011; 290():121-66. PubMed ID: 21875564
[TBL] [Abstract][Full Text] [Related]
15. Endoplasmic Reticulum Protein Disulfide Isomerase Shapes T Cell Efficacy for Adoptive Cellular Therapy of Tumors.
Hurst KE; Lawrence KA; Reyes Angeles L; Ye Z; Zhang J; Townsend DM; Dolloff N; Thaxton JE
Cells; 2019 Nov; 8(12):. PubMed ID: 31779147
[TBL] [Abstract][Full Text] [Related]
16. Small molecule-induced oxidation of protein disulfide isomerase is neuroprotective.
Kaplan A; Gaschler MM; Dunn DE; Colligan R; Brown LM; Palmer AG; Lo DC; Stockwell BR
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):E2245-52. PubMed ID: 25848045
[TBL] [Abstract][Full Text] [Related]
17. Targeting unfolded protein response using albumin-encapsulated nanoparticles attenuates temozolomide resistance in glioblastoma.
Kiang KM; Tang W; Song Q; Liu J; Li N; Lam TL; Shum HC; Zhu Z; Leung GK
Br J Cancer; 2023 May; 128(10):1955-1963. PubMed ID: 36927978
[TBL] [Abstract][Full Text] [Related]
18. Platelet Protein Disulfide Isomerase Promotes Glycoprotein Ibα-Mediated Platelet-Neutrophil Interactions Under Thromboinflammatory Conditions.
Li J; Kim K; Jeong SY; Chiu J; Xiong B; Petukhov PA; Dai X; Li X; Andrews RK; Du X; Hogg PJ; Cho J
Circulation; 2019 Mar; 139(10):1300-1319. PubMed ID: 30586735
[TBL] [Abstract][Full Text] [Related]
19. Targeting the functional interplay between endoplasmic reticulum oxidoreductin-1α and protein disulfide isomerase suppresses the progression of cervical cancer.
Zhang Y; Li T; Zhang L; Shangguan F; Shi G; Wu X; Cui Y; Wang X; Wang X; Liu Y; Lu B; Wei T; Wang CC; Wang L
EBioMedicine; 2019 Mar; 41():408-419. PubMed ID: 30826359
[TBL] [Abstract][Full Text] [Related]
20. Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy.
Tu Z; Wang C; Hu Q; Tao C; Fang Z; Lin L; Lei K; Luo M; Sheng Y; Long X; Li J; Wu L; Huang K; Zhu X
J Exp Clin Cancer Res; 2023 Mar; 42(1):77. PubMed ID: 36997943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
